JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A8174 Cathepsin G Inhibitor I

Target: Cathepsins

Summary: Cathepsin G inhibitor

≥10.35 mg/mL
A3005 CAL-101 (Idelalisib, GS-1101)
8 Citation

Target: PI3K

Summary: PI3K inhibitor
A3017 Dasatinib (BMS-354825)
14 Citation

Summary: Src and Bcr-Abl inhibitor

≥24.4 mg/mL
A3020 (R)-Crizotinib
3 Citation

Target: c-MET

Summary: C-MET/ALK inhibitor,potent and ATP-competitve

insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
A3022 Pazopanib (GW-786034)

Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFR

Summary: VEGFR/PDGFR/FGFR inhibitor

insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL
A2574 Aprotinin
8 Citation

Target: Trypsin|Chymotrypsin|Kallikrein|Trypsinogen

Summary: serine protease inhibitor

≥195 mg/mL
A2576 E-64
6 Citation

Target: Cathepsins|Calpains|Papains

Summary: cysteine proteases inhibitor

≥49.1 mg/mL
A2602 Calpain Inhibitor I, ALLN
5 Citation

Target: Cathepsins|Calpains

Summary: Calpain I/II/ B/L inhibitor
A2577 Batimastat (BB-94)
17 Citation

Summary: MMP inhibitor

≥23.88 mg/mL
A4166 EPZ5676
2 Citation

Target: DOT1L

Summary: DOT1L inhibitor,potent and SAM competitive

≥28.15 mg/mL